Abstract:Objective:To develop a novel doxorubicin (Dox) -loaded chitosan lactate nanoparticles (ChLa-Dox NPs) for experimental treatment of osteosarcoma.Methods:The hydrosoluble chitosan lactate (ChLa) was prepared with 2% aqueous lactic acid solution. In a reaction system with pH=5 and a charge ration of ChLa: TPP=10:1, the ChLa-Dox NPs were generated. Subsequently, dynamic light scattering (DLS) was employed to investigate the particle size distribution, polydispersity (PDI) and Zeta potential. The microstructure of nanoparticles was identified with transmission electron microscopy (TEM) . The biological characterization of ChLa-Dox NPs were explored with multiple assays including in-vitro sustain-release, osteosarcoma cell-line MG63 cytotoxicity, cell migration and flow cytometry.Results:Under pH=5 and a charge ratio of ChLa: TPP=10:1, the genrated ChLa-Dox NPs were 142.4±1.21 μm in size, 0.140±0.01 by PDI, and 29.2 mV by Zeta potential. The controlled release assay in vitro showed that the sustain release of ChLa-Dox Np reached a plateau at 10 h and the accumulative release amount of Dox at 12 h was (69.4±2.6) %. In cell model tests using osteosarcoma MG63 cell-line, the cell viability was 92.36±3.17% in the group treated with blank NPs; in contrast, treatment of osteosarcoma cells with ChLa NPs loaded with different doses of Dox showed significantly cytotoxicity. Compared with blank NPs, ChLa-Dox NPs showed significant inhibition of migration ability and remarkably promotion of apoptosis in osteosarcoma cells [apoptosis rate: (54.08±2.53) %].Conclusion:ChLa-Dox NPs generated with optimized formulation demonstrated efficient release profile and good biocompatibility in vitro. The in-vitro sustain-release kinetics and molecular/cell biological tests on anti-osteosarcoma activity showed that ChLa-Dox NPs exhibited satisfactory properties of doxorubicin sustain-release, effective inhibition of cell proliferation and migration, and promotion of apoptosis of osteosarcoma cells in vitro. These point to a promising prospect of clinical translational attempts.

CPPs-modified chitosan as permeability-enhancing chemotherapeutic combined with gene therapy nanosystem by thermosensitive hydrogel for the treatment of osteosarcoma

Bio-inspired Cisplatin Nanocarriers for Osteosarcoma Treatment.

Synergistic treatment of osteosarcoma with biomimetic nanoparticles transporting doxorubicin and siRNA

Sequentially Degradable Hydrogel-Microsphere Loaded with Doxorubicin and Pioglitazone Synergistically Inhibits Cancer Stemness of Osteosarcoma

Injectable Agarose Hydrogels and Doxorubicin-Encapsulated Iron-Gallic Acid Nanoparticles for Chemodynamic-Photothermal Synergistic Therapy Against Osteosarcoma

Polymersomes of Biodegradable Polysarcosine-Block-poly(ε-caprolactone)

Development of Injectable Thermosensitive Nanocomposite Hydrogel for Ratiometric Drug Delivery to Treat Drug Resistant Chondrosarcoma In Vivo

PLK1shRNA and Doxorubicin Co-Loaded Thermosensitive PLGA-PEG-PLGA Hydrogels for Osteosarcoma Treatment

NIR Responsive Doxorubicin‐Loaded Hollow Copper Ferrite @ Polydopamine for Synergistic Chemodynamic/Photothermal/Chemo‐Therapy

Biomimetic Engineered Nanoparticles Target Drug-Resistant Tumor Cells and Heterogeneous Blood Vessels for Combination Therapy of Osteosarcoma

Thermo-sensitive hydrogel-mediated Locally sequential release of doxorubicin and Palbociclib for chemo-immunotherapy of osteosarcoma

Tumor Microenvironment-Responsive Hyaluronate-Calcium Carbonate Hybrid Nanoparticle Enables Effective Chemotherapy for Primary and Advanced Osteosarcomas

Enhancing Osteosarcoma Killing and CT Imaging Using Ultrahigh Drug Loading and NIR-Responsive Bismuth Sulfide@Mesoporous Silica Nanoparticles

Self‐Stabilized Hyaluronate Nanogel for Intracellular Codelivery of Doxorubicin and Cisplatin to Osteosarcoma

Engineering PDA-coated CM-CS nanoparticles for photothermo-chemotherapy of osteosarcoma and bone regeneration

Co-delivery of Curcumin and Si-Stat3 with a Bioinspired Tumor Homing for Polydopamine Nanoparticles for Synergistic Osteosarcoma Therapy

Effect of a doxorubicin-loaded modified chitosan sustain-release nanoparticle carrier on osteosarcoma cells

Co-delivery of doxorubicin and paclitaxel by reduction/pH dual responsive nanocarriers for osteosarcoma therapy

Photothermally Reinforced Chemodynamic Therapy in the Treatment of Osteosarcoma by Polydopamine-Modified, Copper Peroxide Loaded ZIF8 Nanoparticles

Nanoparticle enhanced combination therapy for stem-like progenitors defined by single-cell transcriptomics in chemotherapy-resistant osteosarcoma

Iron-polydopamine Coated Multifunctional Nanoparticle SiO2@PDA/Fe3+- FA Mediated Low Temperature Photothermal for Chemodynamic Therapy of Cisplatin-Insensitive Osteosarcoma